Elucidating the role of gut microbiota in colitis-associated colorectal cancer

阐明肠道微生物群在结肠炎相关结直肠癌中的作用

基本信息

  • 批准号:
    10564074
  • 负责人:
  • 金额:
    $ 64.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-01-01 至 2027-12-31
  • 项目状态:
    未结题

项目摘要

Abstract Patients with ulcerative colitis (UC), an inflammatory bowel disease (IBD), have an increased risk of developing colitis-associated colorectal cancer (CAC). Human gut microbiome composition has recently been associated with a wide array of diseases, including IBD and colorectal cancer. Studies have shown that gut microbiota could influence colon epithelium to initiate or promote colorectal cancer development directly or indirectly. However, little is known on the structure and function of the microbiota in CAC and how they implicate the development of CAC at the molecular level. In this study, we will investigate the role of microbiota in the development of CAC, as well as the molecular events underlying the interplay of microbiota and host response. The project builds upon our previous studies in examining the genomic instabilities and proteome alterations in the colon epithelium during the pathogenesis of IBD-CAC, and will focus on the mechanistic and functional involvement of the microbiome and their components in the modulation (by protective bacteria) or activation (by tumorigenic bacteria) of CAC development. Specifically, we will investigate the implication of mucosa- associated microbiota in CAC by an integrated approach using three model systems, including clinical specimens (Aim 1), in vitro microbial cultivation and organoid models (Aim 2), and in vivo mouse model (Aim 3). Our integrative, state-of-the-art approach will characterize the composition, functional genes and pathways of the microbiome implicated in CAC, and the impact of microbiota on colon mucosa. By studying the gut microbiota and its interplay with the colon host using novel approaches and cutting-edge technology, our study has significant translational potential that could lead to establishing the gut microbiome as predictors of CAC risk and aid in developing approaches for CAC prevention and detection in IBD patients.
摘要 溃疡性结肠炎(UC)是一种炎症性肠病(IBD), 结肠炎相关的结肠直肠癌(CAC)。人类肠道微生物组组成最近与 包括炎症性肠病和结肠直肠癌在内的一系列疾病。研究表明,肠道微生物群 可能直接或间接影响结肠上皮细胞启动或促进结直肠癌的发生。 然而,对CAC中微生物群的结构和功能以及它们如何影响CAC的研究却知之甚少。 在分子水平上发展CAC。在这项研究中,我们将研究微生物群在 CAC的发展,以及微生物群和宿主反应相互作用的分子事件。 该项目建立在我们以前的研究,在检查基因组不稳定性和蛋白质组改变, 结肠上皮细胞在IBD-CAC发病过程中的作用,并将重点放在机制和功能上, 微生物组及其组分参与调节(通过保护性细菌)或激活 (by致瘤细菌)的CAC发展。具体来说,我们将研究粘膜的含义- 通过使用三个模型系统的综合方法,包括临床 标本(Aim 1)、体外微生物培养和类器官模型(Aim 2)以及体内小鼠模型(Aim 3)。我们的综合,国家的最先进的方法将特点的组成,功能基因和途径 CAC中涉及的微生物组,以及微生物群对结肠粘膜的影响。通过研究肠道 微生物群及其与结肠宿主的相互作用,使用新的方法和尖端技术,我们的研究 具有显著的转化潜力,可能导致建立肠道微生物组作为CAC的预测因子 在IBD患者中预防和检测CAC的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ru Chen其他文献

Ru Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ru Chen', 18)}}的其他基金

Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis
溃疡性结肠炎中结直肠癌早期检测的生物标志物
  • 批准号:
    10172861
  • 财政年份:
    2017
  • 资助金额:
    $ 64.91万
  • 项目类别:
Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis
溃疡性结肠炎中结直肠癌早期检测的生物标志物
  • 批准号:
    10406961
  • 财政年份:
    2017
  • 资助金额:
    $ 64.91万
  • 项目类别:
Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis
溃疡性结肠炎中结直肠癌早期检测的生物标志物
  • 批准号:
    9700068
  • 财政年份:
    2017
  • 资助金额:
    $ 64.91万
  • 项目类别:
Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis
溃疡性结肠炎中结直肠癌早期检测的生物标志物
  • 批准号:
    9382167
  • 财政年份:
    2017
  • 资助金额:
    $ 64.91万
  • 项目类别:
Early detection of pancreatic cancer in diabetics
糖尿病患者胰腺癌的早期发现
  • 批准号:
    9252236
  • 财政年份:
    2014
  • 资助金额:
    $ 64.91万
  • 项目类别:
Early detection of pancreatic cancer in diabetics
糖尿病患者胰腺癌的早期发现
  • 批准号:
    8695193
  • 财政年份:
    2014
  • 资助金额:
    $ 64.91万
  • 项目类别:
Mitochondria proteome of ulcerative colitis associated dysplasia
溃疡性结肠炎相关发育不良的线粒体蛋白质组
  • 批准号:
    8510603
  • 财政年份:
    2012
  • 资助金额:
    $ 64.91万
  • 项目类别:
Mitochondria proteome of ulcerative colitis associated dysplasia
溃疡性结肠炎相关发育不良的线粒体蛋白质组
  • 批准号:
    8374386
  • 财政年份:
    2012
  • 资助金额:
    $ 64.91万
  • 项目类别:
Pancreatic Juice Biomarker for Pancreatic Cancer
胰腺癌的胰液生物标志物
  • 批准号:
    8309082
  • 财政年份:
    2011
  • 资助金额:
    $ 64.91万
  • 项目类别:
Pancreatic Juice Biomarker for Pancreatic Cancer
胰腺癌的胰液生物标志物
  • 批准号:
    8166376
  • 财政年份:
    2011
  • 资助金额:
    $ 64.91万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 64.91万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 64.91万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 64.91万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 64.91万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 64.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 64.91万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 64.91万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 64.91万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 64.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 64.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了